The TheraAIsight Intelligence Suite

Never Start from Zero Ever Again

In the high-stakes world of Life Sciences, the most expensive resource is time. Whether you are an early-stage CEO, a VC analyst, or a commercial leader at a global firm, you shouldn’t have to spend weeks doing desk research just to begin your strategy.

We help you skip the "blank page" phase. Leveraging TheraAIsight, our proprietary AI intelligence platform, we deliver deep-dive market landscapes benchmarks. But we don't just hand you a generic data dump. We customize every report to your specific organization type, asset stage, mechanism of action and objective.

Intelligence That Understands Your Objective

We use AI to bridge the gap between analysis and strategy. By analyzing your asset against the current and forecasted market, we deliver more than just numbers—we provide market fit, development considerations, and actionable takeaways tailored to your goal.

What you receive:

Ready-to-Use Deliverables: Every report is delivered as a polished PDF and a fully editable PowerPoint presentation, customized for your investor meetings or strategic planning.
Clinical Trial Data: Each report includes a CSV export of relevant ClinicalTrials.gov data for your specific indication (for biopharma reports only).
Total Transparency: Every insight is meticulously footnoted and referenced, giving you the confidence to stand behind the data.

Indication Intelligence - For Biopharma

Skip the manual desk research. Get deep-dive biopharma market landscapes with epidemiology, growth forecasts, and patient journeys starting at $650.

Strategic Indication Landscapes: From Epidemiology to Market Access.

We help you navigate the complexities of indication mapping with the precision of a seasoned analyst. By synthesizing etiology, epidemiology, and patient journeys into clear growth forecasts, we identify the exact market fit for your asset. From competitive pipeline analysis to pricing and reimbursement strategies, we provide the deep insights you need to make high-stakes decisions and de-risk your commercial path—all without the typical consulting price tag.

Starting at $650

Credits Program available

Start Your Landscape Analysis

MedTech Strategic Landscape

Quantify the clinical value of your device. Map diagnostic gaps and treated-patient growth to prove market fit and de-risk your commercial path.

Quantifying Clinical Value: From Diagnostic Gaps to Reimbursement Reality.

We help you identify the clear "white space" for your device by mapping the gaps where current diagnostic and monitoring tools fall short. From visualizing the patient journey to forecasting treated-patient growth, we quantify the clinical and economic opportunity for your technology. We provide the HEOR, competitive pipeline, and reimbursement analysis needed to prove market fit and de-risk your commercial path—delivering expert-level clarity at a fraction of the cost.

Starting at $650

Credits Program available

Explore Your Market Potential

Diagnostics Market Navigator

Prove diagnostic value by mapping screening bottlenecks and adoption pathways. Get expert clarity on HEOR and competitive pipelines.

Closing the Diagnostic Gap: Data-Driven Insights from Screening to Reimbursement.

We help you prove the clinical and economic value of your diagnostic innovation. By analyzing current screening and testing algorithms, we identify the specific bottlenecks where new diagnostic tools are most needed. We map the entire patient journey—from initial symptoms to definitive diagnosis—to forecast growth and quantify the market opportunity for your asset. With deep dives into HEOR, competitive pipelines, and reimbursement pathways, we give you the data needed to secure adoption and prove market fit without the excessive consulting fees.

Starting at $650

Credits Program available

Evaluate Your Diagnostic Market

Indication Selection Matrix

De-risk your pipeline by comparing up to 8 potential indications side-by-side. View competitive density and unmet needs with data-backed strategy.

Compare 8 Indications Side-by-Side Market Data.

We help you de-risk your pipeline by transforming "what if" into a data-backed strategy. By comparing up to eight potential indications side-by-side, we provide a multidimensional snapshot of the landscape—from epidemiology and disease complexity to competitive density and unmet needs. We identify the key treating specialists and phenotype nuances for each path, giving you the clarity needed to prioritize your portfolio and move forward with total confidence in your commercial direction.

4 Indications at $400

Additional Indication $200

Inquire for 9+ Indications

Start Your Indication Selection

TPP Strategic Benchmarking

Lead Indication to Safety: Benchmark Your Asset Against the Market.

We help you validate your development path by measuring your Target Product Profile (TPP) against both the current standard of care and the emerging pipeline. By performing a side-by-side analysis of lead indications, patient populations, and specific efficacy and safety endpoints, we pinpoint exactly where your asset stands to lead the market. Our flexible framework allows you to customize the view by drug class or phase of development, ensuring the comparison is always relevant. We even help you visualize the "Ideal TPP" for your specific goals.

Startig at $650

Compare Your TPP

Agile Primary Research

Capture KOL feedback without logistical delays. Use AI for rapid assumption testing and prescriber validation on demand.

Global Dialogue on Demand: From Deep-Dive Interviews to Rapid Expert Pulse Checks.

We help you capture KOL & stakeholder feedback without the logistical delays of traditional primary research. Whether you need to explore prescriber pain points, test the reception of a new mechanism of action, or validate forecast assumptions, the AI platform conducts in-depth interviews on the expert’s schedule.

When you don't need a full-scale study, Pulse Check tool delivers rapid input from a targeted KOLs on your most pressing questions.

Launch Your First Research

Strategic Demand & Revenue Forecast

High-fidelity revenue models for funding rounds and manufacturing plans. Model epidemiology shifts and competitive entry.

Data-Driven Projections for High-Stakes Decisions.

We help you find the rhythm of your market with data-driven forecasts that stand up to the most rigorous scrutiny. Whether you are calculating an asset’s NPV for a funding round or building a long-term manufacturing plan, we provide the technical clarity needed to align your operations with market reality. By modeling the complex mechanics of growth—from epidemiology shifts to competitive entry—we deliver high-fidelity financial and volume models that empower you to make big moves with total confidence.

Add-On to Reports Starting at $1,200

Build Your Forecast

Hi Ai FedFund Opportunity Radar

Automate your federal contract and grant tracking. Receive curated reports on open and forecasted opportunities tailored to your criteria.

Automated Federal Opportunities: Define Your Criteria, Receive Your Opportunities.

We help you streamline your pursuit of Federal contracts and grants by replacing the endless "search and refresh" cycle with a focused "define and receive" workflow.

No matter your industry—from Life Sciences to Defense—we extract both open and forecasted opportunities based on your specific search criteria and deliver a curated report directly to your inbox. We handle the discovery so you can focus on winning the award and scaling your impact.

Activate Your Funding Radar